Hippo DX is a MedTech start-up introducing a state-of-the-art medical device, S.P.A.T. (Skin Prick Automated Test) for automated allergy testing. The S.P.A.T. device executes 12 equal pricks simultaneously in 20 seconds. It images the pricked spots 15 minutes after pricking, offering standardised and digital results for seamless record-keeping. Here are details of Hippo DX‘s latest funding round :
🚀 Launch
2020
🏭 Industry
Medical equipment
🧠Management
Senne Gorris (CEO – Founder), Dirk Loeckx (CTO), Sven Seys (CSO), Sara Shafaq (Chief Business Officer), Bert Vrancx (COO)
💸 Funding & Investors
| INVESTMENT (October 2023) | €4.4 million |
| INVESTORS (October 2023) | Among others, LRM and the American Allerfund Ventures |
🎯 Funding purpose
Operations expansion
🌐 Country HQ
Belgium (Aarschot)